Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Liver transplantation

Evading antigens—ABO-incompatible liver transplantation

Whereas the status of the liver as privileged and exempt from humoral rejection has fallen, attempts at breaching the blood group barrier during transplantation have continued. Previously restricted to paediatric patients and emergencies, advances in immunosuppression protocols have improved outcomes to the point that ABO-incompatible liver transplantation might be more widely used in adults.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Song, G. W. et al. ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab. Am. J. Transplant. http://dx.doi.org/10.1111/ajt.13444.

  2. Starzl, T. E. et al. Fifteen years of clinical liver transplantation. Gastroenterology 77, 375–388 (1979).

    Article  CAS  Google Scholar 

  3. Gordon, R. D. et al. Liver transplantation across ABO blood groups. Surgery 100, 342–348 (1986).

    CAS  PubMed  Google Scholar 

  4. Gugenheim, J., Samuel, D., Reynes, M. & Bismuth, H. Liver transplantation across ABO blood group barriers. Lancet 336, 519–523 (1990).

    Article  CAS  Google Scholar 

  5. Tokunaga, Y. et al. Living related liver transplantation across ABO blood groups with FK506 and OKT3. Transpl. Int. 6, 313–318 (1993).

    Article  CAS  Google Scholar 

  6. Nakamura, Y. et al. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report. Transplant. Proc. 36, 2269–2273 (2004).

    Article  CAS  Google Scholar 

  7. Tanabe, M. et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73, 1959–1961 (2002).

    Article  Google Scholar 

  8. Monteiro, I., McLoughlin, L. M., Fisher, A., de la Torre, A. N. & Koneru, B. Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation. Transplantation 76, 1648–1649 (2003).

    Article  Google Scholar 

  9. Kawagishi, N. et al. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange. Transplant. Proc. 37, 1205–1206 (2005).

    Article  CAS  Google Scholar 

  10. Egawa, H. et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am. J. Transplant. 14, 102–114 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald W. Busuttil.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zarrinpar, A., Busuttil, R. Evading antigens—ABO-incompatible liver transplantation. Nat Rev Gastroenterol Hepatol 12, 676–678 (2015). https://doi.org/10.1038/nrgastro.2015.193

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2015.193

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing